A Study to Evaluate Next Day Effects of MK-4305 on Driving Performance (MK-4305-035 AM1)

Inclusion Criteria: * Female participants of reproductive potential must agree to use (and/or have their partner use) acceptable methods of birth control beginning at least 2 weeks prior to the administration of the first dose of study drug throughout the study * Has a body mass index (BMI) within the range of 18 to 30 kg/m\^2 * Possesses a valid driver's license for 3 years or more with at least 5000 km/year on average within the last 3 years * Is capable of driving a manual transmission vehicle and is willing to drive on a highway * Is judged to be in good health * Has a regular sleep pattern * Is not visually impaired Exclusion Criteria: * Has a history of a persistent sleep abnormality * Has neurological disease/cognitive impairment * Has a history of cataplexy * Is a regular user of sedative-hypnotic agents * Is allergic to zopiclone * Has traveled across 3 or more time zones (transmeridian travel) in the last 2 weeks prior to study start and will travel across 3 or more time zones throughout study duration * Works a night shift and is not able to avoid night shift work within 1 week before each treatment visit * Is pregnant or nursing * Does not qualify as a proficient driver according to the driving instructors evaluation of subject's driving on the driving test practice session